Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclic peptide CXCR4 antagonists

Cyclic peptide CXCR4 antagonists

US Patent 7691813 · Granted Apr 6, 2010

Estimated economic value: $100,386,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Selective CXCR4 binding peptide conjugate and methods for making and using the s2024
Composition comprising a therapeutic agent and a CXCR4 selective antagonist and 2023
Therapeutic peptides2023
KRas G12C inhibitors2023
Therapeutic peptides2022
Selective CXCR4 binding peptide conjugate and methods for making and using the s2021
Therapeutic peptides2021
KRas G12C inhibitors2021
CXCR4 antagonists and methods of use2020
High affinity CXCR4 selective binding conjugate and method for using the same2020
CXCR4 antagonists and methods of use2019
Methods for preparing nickel-cobalt-aluminum precursor material and cathode mate2019